CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 32 enrolled
Drug / intervention
Intravenous lidocaine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02912195
NCT02912195Phase 4Completed
CompareCT.gov

Intravenous Lidocaine Versus Provider Chosen Dose of Morphine for the Treatment of Severe Pain in the Emergency Department: An Open-label Randomized Controlled Pilot Study

Alameda Health System·interventional·Posted Sep 23, 2016·Updated Apr 6, 2020

In Brief

A Phase 4 clinical trial evaluating Intravenous lidocaine and Intravenous morphine for Pain. Completed, enrolled 32 participants across 1 site.

Detailed Summary

Objective: Evaluate the analgesic efficacy of intravenous (IV) lidocaine versus provider chosen dose of IV morphine for the treatment of severe pain in the emergency department. Study design: Open-label, randomized controlled pilot study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedSep 23, 2016
Enrollment StartMar 1, 2016
Primary CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 9.8 years ago

Interventions

Intravenous lidocainedrug

Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes

Intravenous morphinedrug

Emergency department provider chooses appropriate dose of intravenous morphine